DAWN Q1 2021 Earnings — Day One Biopharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

DAWNDay One Biopharmaceuticals, Inc.

$2B

Q1 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$49,000

Operating Income

-$16M

Net Income

-$15M

EPS (Diluted)

$-0.25

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$18M

Stock-Based Comp.

$538,000

Balance Sheet

Total Assets

$161M

Total Liabilities

$3M

Stockholders' Equity

$153M

Cash & Equivalents

$155M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$49,000	-$14,000	-250.0%
Operating Income	-$16M	-$2M	-809.3%
Net Income	-$15M	-$2M	-889.1%